AI Article Synopsis
Article Abstract
Objective: The current study aimed to explore the association of single nucleotide polymorphisms (SNPs) within () and dopamine receptors with schizophrenia and genetic association with risperidone treatment response.
Methods: A total of 690 schizophrenic patients (case group) were selected and 430 healthy people were included as the controls. All patients received risperidone treatment continuously for 8 weeks. Next, peripheral venous blood samples were collected and were subjected to polymerase chain reaction-restriction fragment length polymorphism to amplify and genotype the SNPs within and dopamine receptors. Then, correlation analysis was conducted between Positive and Negative Syndrome Scale improvement rates and SNPs within and the dopamine receptor gene.
Results: The allele of rs11749676 (A) emerged as a key element in reducing schizophrenia risk with statistical significance (<0.001). Remarkably, alleles of rs165774 (G), rs6277 (T), and rs6280 (C) were associated with raised predisposition to schizophrenia (all <0.001). Regarding rs11746641, rs11749676, rs6277, and rs6280, the case group exhibited a lesser frequency of heterozygotes in comparison with wild homozygotes genotype (all <0.001). SNPs ( rs4680, rs6275, rs1801028, and rs6277) were remarkably associated with improvement rates of PANSS total scores (<0.05). SNPs ( rs165599 and rs1801028) were significantly associated with risperidone efficacy on negative symptoms (<0.05).
Conclusion: SNPs and dopamine receptor SNPs were correlated with prevalence of schizophrenia and risperidone treatment efficacy of schizophrenia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722007 | PMC |
| http://dx.doi.org/10.2147/NDT.S148824 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Major depressive disorder (MDD) is one of the most common diseases affecting millions of people worldwide. The use of existing antidepressants in many cases does not allow achieving stable remission, probably due to insufficient understanding of pathological mechanisms. This indicates the need for the development of more effective drugs based on in-depth understanding of MDD's pathophysiology.
View Article and Find Full Text PDFRole of D1- and D2-like dopamine receptors within the CA1 hippocampal region in the stress-induced antinociceptive response in the exposure to acute pain.
Behav Pharmacol
December 2024
Neuroscience Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences.
Exposure to stressful conditions such as forced swim stress (FSS) induces antinociception. Previous reports determined that dopamine receptors in the CA1 hippocampal area are important in chronic pain processing. Considering that neural mechanisms behind acute and chronic pain differ significantly, in this study, we have investigated the role of dopamine receptors within the CA1 region in the FSS-induced antinociceptive response in the acute pain induced by the tail-flick test in the rat.
View Article and Find Full Text PDFSynaptic modulation of glutamate in striatum of the YAC128 mouse model of Huntington disease.
Neurobiol Dis
December 2024
Department of Psychiatry, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada. Electronic address:
Background: Altered balance between striatal direct and indirect pathways contributes to early motor, cognitive and psychiatric symptoms in Huntington disease (HD). While degeneration of striatal D2-type dopamine receptor (D2)-expressing indirect pathway medium spiny neurons (iMSNs) occurs prior to that of D1-type dopamine receptor (D1)-expressing direct pathway neurons, altered corticostriatal synaptic function precedes degeneration. D2-mediated signaling on iMSNs reduces their excitability and promotes endocannabinoid (eCB) synthesis, suppressing glutamate release from cortical afferents.
View Article and Find Full Text PDFBinding of Bioactive Ammonium Ions in Water with a Cavity-Based Selectivity: Water Solubilization versus Micellar Incorporation.
J Org Chem
December 2024
Ecole polytechnique de Bruxelles, Engineering of Molecular NanoSystems, Université libre de Bruxelles (ULB), Avenue F. D. Roosevelt 50, CP165/64, B-1050 Brussels, Belgium.
Many bioactive molecules contain primary ammonium groups, generating significant interest in developing selective receptors for ammonium ions. A promising strategy involves the use of polyaromatic cavitands to achieve size and shape selectivity through their cavity. However, designing effective receptors for ammonium ions in aqueous media is challenging due to the competitive nature of water.
View Article and Find Full Text PDFReversal of the motivational effects of tetrabenazine by NMDA receptor blockade.
Neuropharmacology
December 2024
- Department of Psychopharmacology, Valdman Institute of Pharmacology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
Background: Apathy is a syndrome of decreased goal-directed activity, one of the main features of different brain disorders. Despite its high prevalence and life-threatening potential, there are currently very few options for its pharmacological treatment, which may be related to the lack of valid animal models.
Aims: The vesicular monoamine transporter 2 inhibitor tetrabenazine (TBZ) was used in this study to model apathy-related behavior in pathologies linked to a depletion of dopamine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!